# Quality Assurance Report

## Identity

| Field | Value |
|---|---|
| QA Report ID | QA-PP-0172 |
| PP ID | PP-0172 |
| Title | Serum Pepsinogen Screening |
| Version | 1.0.0 |
| Status | PASS — GOLD |

# Layer 1 — Content QA

| Criterion | Result |
|---|---|
| Single atomic clinical question | PASS |
| Approved scope preserved | PASS |
| Full-depth CKO | PASS |
| Full-depth Knowledge Passport | PASS |
| Full-depth Evidence Package | PASS |
| Knowledge blocks sufficiently granular | PASS |
| Common misconceptions included | PASS |
| Key messages included | PASS |
| Knowledge Graph included | PASS |
| Boundary included | PASS |

# Layer 2 — Clinical QA

| Criterion | Result |
|---|---|
| Source-grounded clinical claims | PASS |
| NCI/NCCN terminology preserved | PASS |
| No unsupported universal threshold | PASS |
| No invented screening interval | PASS |
| No invented individualized risk | PASS |
| Risk not equated with diagnosis | PASS |
| Observational evidence identified as observational | PASS |
| Population-specific evidence not overgeneralized | PASS |
| Evidence gaps explicit | PASS |
| Downstream clinical ownership preserved | PASS |

# Layer 3 — Educational QA

| Criterion | Result |
|---|---|
| Plain-language explanation | PASS |
| Medical terms explained | PASS |
| One major concept per knowledge block | PASS |
| Patient-facing relevance | PASS |
| Neutral tone | PASS |
| Uncertainty visible | PASS |
| Misconceptions addressed | PASS |
| No alarmist language | PASS |
| No individualized medical instruction | PASS |

# Layer 4 — Governance QA

| Criterion | Result |
|---|---|
| Source-First rule respected | PASS |
| Gold artifact structure preserved | PASS |
| Gold reference depth preserved | PASS |
| No compacted artifact treatment | PASS |
| Evidence traceability | PASS |
| Boundary ownership | PASS |
| Adjacent PP overlap checked | PASS |
| Knowledge Graph linkage | PASS |
| Semantic versioning | PASS |
| Repository-ready structure | PASS |
| Four-artifact ZIP | PASS |

# Gold Depth QA

This reproduction is intentionally **not compacted**.

The four artifacts contain:

- full CKO metadata, objectives, scope, detailed knowledge blocks, misconceptions, key messages, graph and revision history;
- full Knowledge Passport with classification, journey, runtime use, retrieval intent, graph, scope, sources, evidence classification, governance and versioning;
- full Evidence Package with clinical question, evidence hierarchy, matrix, evidence notes, claims, gaps, delegation, update triggers, traceability and boundary verification;
- four-layer QA plus clinical safety, evidence, boundary and architecture checks.

The package is permitted to be **deeper than the reference**, but not shorter or materially less granular.

# Boundary QA

**Core = serum pepsinogen as a blood-based gastric-cancer risk/precursor marker, relationship with atrophic gastritis and intestinal-type cancer risk, PGI/PGII concept, study-specific cutoffs and performance, medication/eradication effects, evidence limitations, and patient-facing interpretation; Supporting = atrophic gastritis context, endoscopic follow-up concept, high-risk population context, and false-result concepts; Explicitly Excluded = universal cutoff algorithms, detailed laboratory methodology, H. pylori testing/eradication treatment, PPI management, diagnostic endoscopy, biopsy/pathology, individualized screening recommendation, and treatment; Delegated-to PP = PP-0165, PP-0160, PP-0170, PP-0171, PP-0173, PP-0174, PP-0175, PP-0177, PP-0178, and downstream management.**

# Architecture QA

The package remains an atomic PP and does not absorb the substantive ownership of adjacent PPs.

# Final QA Decision

## PASS

The artifact set satisfies the locked Gold Population Package structure and the standing full-depth production rule.

# QA Final Status

**PASS — GOLD — READY FOR INTEGRATION.**
